APO Research
Talk to an analyst

APO RESEARCH · REPORT

Neurotrophins

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Neurotrophins Industry Growth and Trends Forecast to 2032

19 December 202593 pages

Choose your research edition.

Industry ResearchNeurotrophins Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Neurotrophins Industry Growth and Trends Forecast to 203293 pages · $3,450 USDMarket StructureGlobal Neurotrophins Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Neurotrophins Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Neurotrophins Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Neurotrophins market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Neurotrophins is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Neurotrophins is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Neurotrophins is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Neurotrophins include FibroGen, GE Healthcare, Merck Serono, PeproTech, Scil Proteins GmbH, Scil Proteins GmbH, Lonza Groups and Johnson＆Johnson, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Neurotrophins market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Neurotrophins market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Neurotrophins market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Neurotrophins.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Neurotrophins market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Neurotrophins Market by Company

FibroGen

GE Healthcare

Merck Serono

PeproTech

Scil Proteins GmbH

Scil Proteins GmbH

Lonza Groups

Johnson＆Johnson

Neurotrophins Segment by Type

Dehydroepiandrosterone Sulfate

Brain-Derived Neurotrophic Factor

Nerve Growth Factor

Other

Neurotrophins Segment by Application

Alzheimer'S Disease

Amyotrophic Lateral Sclerosis

Parkinson'S Disease

Other

Neurotrophins Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Neurotrophins market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Neurotrophins and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Neurotrophins.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Neurotrophins manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Neurotrophins in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Dehydroepiandrosterone Sulfate Table 2. Major Company of Brain-Derived Neurotrophic Factor Table 3. Major Company of Nerve Growth Factor Table 4. Major Company of Other Table 5. Global Neurotrophins Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Neurotrophins Sales by Type (2021-2026) & (K Units) Table 7. Global Neurotrophins Sales Market Share in Volume by Type (2021-2026) Table 8. Global Neurotrophins Sales by Type (2021-2026) & (US$ Million) Table 9. Global Neurotrophins Sales Market Share in Value by Type (2021-2026) Table 10. Global Neurotrophins Price by Type (2021-2026) & (US$/Unit) Table 11. Global Neurotrophins Sales by Type (2027-2032) & (K Units) Table 12. Global Neurotrophins Sales Market Share in Volume by Type (2027-2032) Table 13. Global Neurotrophins Sales by Type (2027-2032) & (US$ Million) Table 14. Global Neurotrophins Sales Market Share in Value by Type (2027-2032) Table 15. Global Neurotrophins Price by Type (2027-2032) & (US$/Unit) Table 16. North America Neurotrophins Sales by Type (2021-2026) & (K Units) Table 17. North America Neurotrophins Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Neurotrophins Sales by Type (2021-2026) & (K Units) Table 19. Europe Neurotrophins Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Neurotrophins Sales by Type (2021-2026) & (K Units) Table 21. Asia-Pacific Neurotrophins Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Neurotrophins Sales by Type (2021-2026) & (K Units) Table 23. Latin America Neurotrophins Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Neurotrophins Sales by Type (2021-2026) & (K Units) Table 25. Middle East and Africa Neurotrophins Sales by Type (2021-2026) & (US$ Million) Table 26. Neurotrophins Industry Trends Table 27. Neurotrophins Industry Drivers Table 28. Neurotrophins Industry Opportunities and Challenges Table 29. Neurotrophins Industry Restraints Table 30. Global Neurotrophins Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Neurotrophins Revenue Market Share by Company (2021-2026) Table 32. Global Neurotrophins Sales by Company (2021-2026) & (K Units) Table 33. Global Neurotrophins Sales Share by Company (2021-2026) Table 34. Global Neurotrophins Market Price by Company (2021-2026) & (US$/Unit) Table 35. Global Neurotrophins Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Neurotrophins Major Company Production Sites and Headquarters Table 37. Global Neurotrophins Company, Product Type & Application Table 38. Global Neurotrophins Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Neurotrophins by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Neurotrophins Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Neurotrophins Sales by Region (2021-2026) & (K Units) Table 43. Global Neurotrophins Sales Market Share in Volume by Region (2021-2026) Table 44. Global Neurotrophins Sales by Region (2021-2026) & (US$ Million) Table 45. Global Neurotrophins Sales Market Share in Value by Region (2021-2026) Table 46. Global Neurotrophins Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 47. Global Neurotrophins Sales by Region (2027-2032) & (K Units) Table 48. Global Neurotrophins Sales Market Share in Volume by Region (2027-2032) Table 49. Global Neurotrophins Sales by Region (2027-2032) & (US$ Million) Table 50. Global Neurotrophins Sales Market Share in Value by Region (2027-2032) Table 51. Global Neurotrophins Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 52. Global Neurotrophins Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Neurotrophins Sales by Application (2021-2026) & (K Units) Table 54. Global Neurotrophins Sales Market Share in Volume by Application (2021-2026) Table 55. Global Neurotrophins Sales by Application (2021-2026) & (US$ Million) Table 56. Global Neurotrophins Sales Market Share in Value by Application (2021-2026) Table 57. Global Neurotrophins Price by Application (2021-2026) & (US$/Unit) Table 58. Global Neurotrophins Sales by Application (2027-2032) & (K Units) Table 59. Global Neurotrophins Sales Market Share in Volume by Application (2027-2032) Table 60. Global Neurotrophins Sales by Application (2027-2032) & (US$ Million) Table 61. Global Neurotrophins Sales Market Share in Value by Application (2027-2032) Table 62. Global Neurotrophins Price by Application (2027-2032) & (US$/Unit) Table 63. North America Neurotrophins Sales by Application (2021-2026) & (K Units) Table 64. North America Neurotrophins Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Neurotrophins Sales by Application (2021-2026) & (K Units) Table 66. Europe Neurotrophins Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Neurotrophins Sales by Application (2021-2026) & (K Units) Table 68. Asia-Pacific Neurotrophins Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Neurotrophins Sales by Application (2021-2026) & (K Units) Table 70. Latin America Neurotrophins Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Neurotrophins Sales by Application (2021-2026) & (K Units) Table 72. Middle East and Africa Neurotrophins Sales by Application (2021-2026) & (US$ Million) Table 73. FibroGen Company Information Table 74. FibroGen Business Overview Table 75. FibroGen Neurotrophins Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. FibroGen Neurotrophins Product Portfolio Table 77. FibroGen Recent Development Table 78. GE Healthcare Company Information Table 79. GE Healthcare Business Overview Table 80. GE Healthcare Neurotrophins Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. GE Healthcare Neurotrophins Product Portfolio Table 82. GE Healthcare Recent Development Table 83. Merck Serono Company Information Table 84. Merck Serono Business Overview Table 85. Merck Serono Neurotrophins Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Merck Serono Neurotrophins Product Portfolio Table 87. Merck Serono Recent Development Table 88. PeproTech Company Information Table 89. PeproTech Business Overview Table 90. PeproTech Neurotrophins Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. PeproTech Neurotrophins Product Portfolio Table 92. PeproTech Recent Development Table 93. Scil Proteins GmbH Company Information Table 94. Scil Proteins GmbH Business Overview Table 95. Scil Proteins GmbH Neurotrophins Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Scil Proteins GmbH Neurotrophins Product Portfolio Table 97. Scil Proteins GmbH Recent Development Table 98. Scil Proteins GmbH Company Information Table 99. Scil Proteins GmbH Business Overview Table 100. Scil Proteins GmbH Neurotrophins Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Scil Proteins GmbH Neurotrophins Product Portfolio Table 102. Scil Proteins GmbH Recent Development Table 103. Lonza Groups Company Information Table 104. Lonza Groups Business Overview Table 105. Lonza Groups Neurotrophins Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Lonza Groups Neurotrophins Product Portfolio Table 107. Lonza Groups Recent Development Table 108. Johnson＆Johnson Company Information Table 109. Johnson＆Johnson Business Overview Table 110. Johnson＆Johnson Neurotrophins Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Johnson＆Johnson Neurotrophins Product Portfolio Table 112. Johnson＆Johnson Recent Development Table 113. North America Neurotrophins Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 114. North America Neurotrophins Sales by Country (2021-2026) & (K Units) Table 115. North America Neurotrophins Sales Market Share by Country (2021-2026) Table 116. North America Neurotrophins Sales Forecast by Country (2027-2032) & (K Units) Table 117. North America Neurotrophins Sales Market Share Forecast by Country (2027-2032) Table 118. North America Neurotrophins Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 119. North America Neurotrophins Market Size by Country (2021-2026) & (US$ Million) Table 120. North America Neurotrophins Market Share by Country (2021-2026) Table 121. North America Neurotrophins Market Size Forecast by Country (2027-2032) & (US$ Million) Table 122. North America Neurotrophins Market Share Forecast by Country (2027-2032) Table 123. Europe Neurotrophins Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 124. Europe Neurotrophins Sales by Country (2021-2026) & (K Units) Table 125. Europe Neurotrophins Sales Market Share by Country (2021-2026) Table 126. Europe Neurotrophins Sales Forecast by Country (2027-2032) & (K Units) Table 127. Europe Neurotrophins Sales Market Share Forecast by Country (2027-2032) Table 128. Europe Neurotrophins Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. Europe Neurotrophins Market Size by Country (2021-2026) & (US$ Million) Table 130. Europe Neurotrophins Market Share by Country (2021-2026) Table 131. Europe Neurotrophins Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. Europe Neurotrophins Market Share Forecast by Country (2027-2032) Table 133. Asia-Pacific Neurotrophins Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 134. Asia-Pacific Neurotrophins Sales by Country (2021-2026) & (K Units) Table 135. Asia-Pacific Neurotrophins Sales Market Share by Country (2021-2026) Table 136. Asia-Pacific Neurotrophins Sales Forecast by Country (2027-2032) & (K Units) Table 137. Asia-Pacific Neurotrophins Sales Market Share Forecast by Country (2027-2032) Table 138. Asia-Pacific Neurotrophins Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. Asia-Pacific Neurotrophins Market Size by Country (2021-2026) & (US$ Million) Table 140. Asia-Pacific Neurotrophins Market Share by Country (2021-2026) Table 141. Asia-Pacific Neurotrophins Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. Asia-Pacific Neurotrophins Market Share Forecast by Country (2027-2032) Table 143. Latin America Neurotrophins Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 144. Latin America Neurotrophins Sales by Country (2021-2026) & (K Units) Table 145. Latin America Neurotrophins Sales Market Share by Country (2021-2026) Table 146. Latin America Neurotrophins Sales Forecast by Country (2027-2032) & (K Units) Table 147. Latin America Neurotrophins Sales Market Share Forecast by Country (2027-2032) Table 148. Latin America Neurotrophins Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Latin America Neurotrophins Market Size by Country (2021-2026) & (US$ Million) Table 150. Latin America Neurotrophins Market Share by Country (2021-2026) Table 151. Latin America Neurotrophins Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Latin America Neurotrophins Market Share Forecast by Country (2027-2032) Table 153. Middle East and Africa Neurotrophins Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 154. Middle East and Africa Neurotrophins Sales by Country (2021-2026) & (K Units) Table 155. Middle East and Africa Neurotrophins Sales Market Share by Country (2021-2026) Table 156. Middle East and Africa Neurotrophins Sales Forecast by Country (2027-2032) & (K Units) Table 157. Middle East and Africa Neurotrophins Sales Market Share Forecast by Country (2027-2032) Table 158. Middle East and Africa Neurotrophins Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. Middle East and Africa Neurotrophins Market Size by Country (2021-2026) & (US$ Million) Table 160. Middle East and Africa Neurotrophins Market Share by Country (2021-2026) Table 161. Middle East and Africa Neurotrophins Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. Middle East and Africa Neurotrophins Market Share Forecast by Country (2027-2032) Table 163. Key Raw Materials Table 164. Raw Materials Key Suppliers Table 165. Neurotrophins Distributors List Table 166. Neurotrophins Customers List Table 167. Research Programs/Design for This Report Table 168. Authors List of This Report Table 169. Secondary Sources Table 170. Primary Sources List of Figures Figure 1. Neurotrophins Image Figure 2. Global Neurotrophins Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Neurotrophins Market Size (2021-2032) & (US$ Million) Figure 4. Global Neurotrophins Sales (2021-2032) & (K Units) Figure 5. Dehydroepiandrosterone Sulfate Image Figure 6. Global Dehydroepiandrosterone Sulfate Sales YoY Growth (2021-2032) & (K Units) Figure 7. Brain-Derived Neurotrophic Factor Image Figure 8. Global Brain-Derived Neurotrophic Factor Sales YoY Growth (2021-2032) & (K Units) Figure 9. Nerve Growth Factor Image Figure 10. Global Nerve Growth Factor Sales YoY Growth (2021-2032) & (K Units) Figure 11. Other Image Figure 12. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 13. Global Neurotrophins Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Neurotrophins Market Share by Type 2025 VS 2032 Figure 15. North America Neurotrophins Sales Market Share in Volume by Type in 2025 Figure 16. North America Neurotrophins Sales Market Share in Value by Type in 2025 Figure 17. Europe Neurotrophins Sales Market Share in Volume by Type in 2025 Figure 18. Europe Neurotrophins Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Neurotrophins Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Neurotrophins Sales Market Share in Value by Type in 2025 Figure 21. Latin America Neurotrophins Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Neurotrophins Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Neurotrophins Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Neurotrophins Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Neurotrophins Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Alzheimer'S Disease Image Figure 28. Global Alzheimer'S Disease Sales YoY Growth (2021-2032) & (K Units) Figure 29. Amyotrophic Lateral Sclerosis Image Figure 30. Global Amyotrophic Lateral Sclerosis Sales YoY Growth (2021-2032) & (K Units) Figure 31. Parkinson'S Disease Image Figure 32. Global Parkinson'S Disease Sales YoY Growth (2021-2032) & (K Units) Figure 33. Other Image Figure 34. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 35. Global Neurotrophins Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Neurotrophins Market Share by Application 2025 VS 2032 Figure 37. North America Neurotrophins Sales Market Share in Volume by Application in 2025 Figure 38. North America Neurotrophins Sales Market Share in Value by Application in 2025 Figure 39. Europe Neurotrophins Sales Market Share in Volume by Application in 2025 Figure 40. Europe Neurotrophins Sales Market Share in Value by Application in 2025 Figure 41. Asia-Pacific Neurotrophins Sales Market Share in Volume by Application in 2025 Figure 42. Asia-Pacific Neurotrophins Sales Market Share in Value by Application in 2025 Figure 43. Latin America Neurotrophins Sales Market Share in Volume by Application in 2025 Figure 44. Latin America Neurotrophins Sales Market Share in Value by Application in 2025 Figure 45. Middle East and Africa Neurotrophins Sales Market Share in Volume by Application in 2025 Figure 46. Middle East and Africa Neurotrophins Sales Market Share in Value by Application in 2025 Figure 47. North America Neurotrophins Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. North America Neurotrophins Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. North America Neurotrophins Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. North America Neurotrophins Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Neurotrophins Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Europe Neurotrophins Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Neurotrophins Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe Neurotrophins Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Neurotrophins Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Asia-Pacific Neurotrophins Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Neurotrophins Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Asia-Pacific Neurotrophins Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Neurotrophins Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Latin America Neurotrophins Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Neurotrophins Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Latin America Neurotrophins Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Neurotrophins Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 64. Middle East and Africa Neurotrophins Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Neurotrophins Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Middle East and Africa Neurotrophins Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Neurotrophins Value Chain Figure 68. Key Raw Materials Price Figure 69. Manufacturing Cost Structure Figure 70. Neurotrophins Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Dehydroepiandrosterone Sulfate
  • Brain-Derived Neurotrophic Factor
  • Nerve Growth Factor
  • Other
Applications
  • Alzheimer'S Disease
  • Amyotrophic Lateral Sclerosis
  • Parkinson'S Disease
  • Other
Companies covered
  • FibroGen
  • GE Healthcare
  • Merck Serono
  • PeproTech
  • Scil Proteins GmbH
  • Scil Proteins GmbH
  • Lonza Groups
  • Johnson＆Johnson

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Neurotrophins Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Neurotrophins Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Neurotrophins Market by Type
  6. 1.3.1 Dehydroepiandrosterone Sulfate
  7. 1.3.2 Brain-Derived Neurotrophic Factor
  8. 1.3.3 Nerve Growth Factor
  9. 1.3.4 Other
  10. 1.4 Global Neurotrophins Market Size by Type
  11. 1.4.1 Global Neurotrophins Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Neurotrophins Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Neurotrophins Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Neurotrophins Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Neurotrophins Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Neurotrophins Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Neurotrophins Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Neurotrophins Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Neurotrophins Industry Trends
  2. 2.2 Neurotrophins Industry Drivers
  3. 2.3 Neurotrophins Industry Opportunities and Challenges
  4. 2.4 Neurotrophins Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Neurotrophins Revenue (2021-2026)
  2. 3.2 Global Top Players by Neurotrophins Sales (2021-2026)
  3. 3.3 Global Top Players by Neurotrophins Price (2021-2026)
  4. 3.4 Global Neurotrophins Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Neurotrophins Major Company Production Sites & Headquarters
  6. 3.6 Global Neurotrophins Company, Product Type & Application
  7. 3.7 Global Neurotrophins Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Neurotrophins Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Neurotrophins Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Neurotrophins Tier 1, Tier 2, and Tier 3
4 Neurotrophins Regional Status and Outlook
  1. 4.1 Global Neurotrophins Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Neurotrophins Historic Market Size by Region
  3. 4.2.1 Global Neurotrophins Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Neurotrophins Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Neurotrophins Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Neurotrophins Forecasted Market Size by Region
  7. 4.3.1 Global Neurotrophins Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Neurotrophins Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Neurotrophins Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Neurotrophins by Application
  1. 5.1 Neurotrophins Market by Application
  2. 5.1.1 Alzheimer'S Disease
  3. 5.1.2 Amyotrophic Lateral Sclerosis
  4. 5.1.3 Parkinson'S Disease
  5. 5.1.4 Other
  6. 5.2 Global Neurotrophins Market Size by Application
  7. 5.2.1 Global Neurotrophins Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Neurotrophins Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Neurotrophins Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Neurotrophins Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Neurotrophins Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Neurotrophins Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Neurotrophins Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Neurotrophins Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 FibroGen
  2. 6.1.1 FibroGen Company Information
  3. 6.1.2 FibroGen Business Overview
  4. 6.1.3 FibroGen Neurotrophins Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 FibroGen Neurotrophins Product Portfolio
  6. 6.1.5 FibroGen Recent Developments
  7. 6.2 GE Healthcare
  8. 6.2.1 GE Healthcare Company Information
  9. 6.2.2 GE Healthcare Business Overview
  10. 6.2.3 GE Healthcare Neurotrophins Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 GE Healthcare Neurotrophins Product Portfolio
  12. 6.2.5 GE Healthcare Recent Developments
  13. 6.3 Merck Serono
  14. 6.3.1 Merck Serono Company Information
  15. 6.3.2 Merck Serono Business Overview
  16. 6.3.3 Merck Serono Neurotrophins Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Merck Serono Neurotrophins Product Portfolio
  18. 6.3.5 Merck Serono Recent Developments
  19. 6.4 PeproTech
  20. 6.4.1 PeproTech Company Information
  21. 6.4.2 PeproTech Business Overview
  22. 6.4.3 PeproTech Neurotrophins Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 PeproTech Neurotrophins Product Portfolio
  24. 6.4.5 PeproTech Recent Developments
  25. 6.5 Scil Proteins GmbH
  26. 6.5.1 Scil Proteins GmbH Company Information
  27. 6.5.2 Scil Proteins GmbH Business Overview
  28. 6.5.3 Scil Proteins GmbH Neurotrophins Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Scil Proteins GmbH Neurotrophins Product Portfolio
  30. 6.5.5 Scil Proteins GmbH Recent Developments
  31. 6.6 Scil Proteins GmbH
  32. 6.6.1 Scil Proteins GmbH Company Information
  33. 6.6.2 Scil Proteins GmbH Business Overview
  34. 6.6.3 Scil Proteins GmbH Neurotrophins Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Scil Proteins GmbH Neurotrophins Product Portfolio
  36. 6.6.5 Scil Proteins GmbH Recent Developments
  37. 6.7 Lonza Groups
  38. 6.7.1 Lonza Groups Company Information
  39. 6.7.2 Lonza Groups Business Overview
  40. 6.7.3 Lonza Groups Neurotrophins Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Lonza Groups Neurotrophins Product Portfolio
  42. 6.7.5 Lonza Groups Recent Developments
  43. 6.8 Johnson＆Johnson
  44. 6.8.1 Johnson＆Johnson Company Information
  45. 6.8.2 Johnson＆Johnson Business Overview
  46. 6.8.3 Johnson＆Johnson Neurotrophins Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Johnson＆Johnson Neurotrophins Product Portfolio
  48. 6.8.5 Johnson＆Johnson Recent Developments
7 North America by Country
  1. 7.1 North America Neurotrophins Sales by Country
  2. 7.1.1 North America Neurotrophins Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Neurotrophins Sales by Country (2021-2026)
  4. 7.1.3 North America Neurotrophins Sales Forecast by Country (2027-2032)
  5. 7.2 North America Neurotrophins Market Size by Country
  6. 7.2.1 North America Neurotrophins Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Neurotrophins Market Size by Country (2021-2026)
  8. 7.2.3 North America Neurotrophins Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Neurotrophins Sales by Country
  2. 8.1.1 Europe Neurotrophins Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Neurotrophins Sales by Country (2021-2026)
  4. 8.1.3 Europe Neurotrophins Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Neurotrophins Market Size by Country
  6. 8.2.1 Europe Neurotrophins Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Neurotrophins Market Size by Country (2021-2026)
  8. 8.2.3 Europe Neurotrophins Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Neurotrophins Sales by Country
  2. 9.1.1 Asia-Pacific Neurotrophins Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Neurotrophins Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Neurotrophins Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Neurotrophins Market Size by Country
  6. 9.2.1 Asia-Pacific Neurotrophins Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Neurotrophins Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Neurotrophins Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Neurotrophins Sales by Country
  2. 10.1.1 South America Neurotrophins Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Neurotrophins Sales by Country (2021-2026)
  4. 10.1.3 South America Neurotrophins Sales Forecast by Country (2027-2032)
  5. 10.2 South America Neurotrophins Market Size by Country
  6. 10.2.1 South America Neurotrophins Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Neurotrophins Market Size by Country (2021-2026)
  8. 10.2.3 South America Neurotrophins Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Neurotrophins Sales by Country
  2. 11.1.1 Middle East and Africa Neurotrophins Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Neurotrophins Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Neurotrophins Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Neurotrophins Market Size by Country
  6. 11.2.1 Middle East and Africa Neurotrophins Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Neurotrophins Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Neurotrophins Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Neurotrophins Value Chain Analysis
  2. 12.1.1 Neurotrophins Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Neurotrophins Production Mode & Process
  7. 12.2 Neurotrophins Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Neurotrophins Distributors
  10. 12.2.3 Neurotrophins Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst